Neogen Chemicals Limited has announced robust financial results for the first quarter of FY27, with consolidated revenue soaring by 34% year-on-year to INR 250 crore. The company also reported a significant 67% increase in profit after tax to INR 17 crore. Driven by this strong performance, Neogen Chemicals has revised its revenue guidance for FY27 upwards to INR 950–1,050 crore.
Strong Start to FY27
Neogen Chemicals Limited has kicked off the financial year 2027 with a strong performance, showcasing significant year-on-year growth across its key financial metrics. The company announced its Q1 FY27 results, highlighting a consolidated revenue of INR 250 crore, marking a substantial 34% increase compared to the same period last year. This impressive revenue growth was primarily driven by increased volumes across its core business verticals, sustained customer demand, and a record quarterly revenue from its organo-lithium and battery chemicals portfolios.
Profitability and Margins
EBITDA for the quarter grew by a remarkable 53% year-on-year to INR 48 crore, with EBITDA margins expanding by 260 basis points to 19.3%. Profit after tax surged by 67% year-on-year to INR 17 crore, achieving a PAT margin of 6.8%. The company’s base business demonstrated resilience amidst global supply chain volatility by successfully implementing cost pass-through mechanisms for raw materials and input costs.
Revised Revenue Guidance
Buoyed by the strong Q1 performance and the growing opportunities in the battery materials segment, Neogen Chemicals has revised its revenue guidance for the full fiscal year 2027. The company now anticipates revenue to be in the range of INR 950 crore to INR 1,050 crore, an upward revision from its previous guidance of INR 875 crore to INR 950 crore. This revised guidance reflects the company’s confidence in its growth trajectory, particularly in the battery materials and organo-lithium segments.
Operational Updates
Key operational highlights for the quarter include the near-complete reconstruction of the Dahej plant, with commercial production set to commence in Q2 FY27. Neogen Ionics also reported a robust performance, generating INR 19 crore in revenue compared to INR 5 crore in Q1 FY26. The company is on track for commissioning its electrolyte facility in H1 FY27 and lithium electrolyte salts in H2 FY27. Furthermore, the Board has approved a fundraise of INR 600 crore through a QIP to support long-term capital requirements and future growth opportunities in battery materials and organo-lithium spaces.
Source: BSE
